Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.

Date publication

mars 2022

Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Pr NOEL Georges , Mme CHAMBRELANT Isabelle , Dr LE FEVRE Clara , Dr BUND Caroline

Tous les auteurs :
Kuntz L, Le Fèvre C, Jarnet D, Keller A, Meyer P, Bund C, Chambrelant I, Antoni D, Noel G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35294567

Résumé

Forty to sixty percent of patients treated with focal therapy for brain metastasis (BM) will have distant brain recurrence (C-LR), while 10-25% of patients will have local recurrence (LR) within 1 year after stereotactic radiotherapy (SRT). The purpose of this study was to analyze cerebral progression-free survival (C-PFS) and LR of BM among patients treated with repeated courses of radiotherapy in stereotactic conditions.

Mots clés

Brain recurrence, Magnetic resonance imaging, Neoplasm metastases, Reirradiation, Repeated radiosurgery

Référence

Strahlenther Onkol. 2022 Mar 16;: